Association of long-term exposure to ambient air pollution with retinal neurodegeneration: the prospective Alienor study.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 13 02 2023
revised: 23 05 2023
accepted: 07 06 2023
medline: 17 7 2023
pubmed: 11 6 2023
entrez: 10 6 2023
Statut: ppublish

Résumé

Chronic exposure to air pollution may have adverse effects on neurodegenerative diseases. Glaucoma, the second leading cause of blindness worldwide, is a neurodegenerative disease of the optic nerve, characterized by progressive thinning of the retinal nerve fiber layer (RNFL). We investigated the relationship of air pollution exposure with longitudinal changes of RNFL thickness in the Alienor study, a population-based cohort of residents of Bordeaux, France, aged 75 years or more. Peripapillary RNFL thickness was measured using optical coherence tomography imaging every 2 years from 2009 to 2020. Measurements were acquired and reviewed by specially trained technicians to control quality. Air pollution exposure (particulate matter ≤2.5 μm (PM

Identifiants

pubmed: 37301495
pii: S0013-9351(23)01168-4
doi: 10.1016/j.envres.2023.116364
pii:
doi:

Substances chimiques

Nitrogen Dioxide S7G510RUBH
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116364

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Cécile Delcourt : Consultant for Allergan, Bausch+Lomb, Laboratoires Théa and Novartis. Audrey Cougnard-Grégoire : Travel fees from Laboratoires Théa. Jean-François Korobelnik : Consultant pour Abbvie, Apellis, Bayer, Janssen, Nanoretina, Roche, Théa, Carl Zeiss Meditec. Membre du DSMB pour Alexion, Nonordisk. Marie-Noelle Delyfer: Consultant for AbbVie, Bayer, Horama, Horus Pharma, Novartis, Roche et Thea. Cédric Schweitzer: Consultant for Abbvie, Alcon, Glaukos, Nicox, Théa, Horus, Johnson & Johnson, Santen, Bausch & Lomb. Laure Gayraud, Marion Mortamais, Kees de Hoogh, Marie-Bénédicte Rougier, Karen Leffondré, Catherine Helmer, Danielle Vienneau, Claudine Berr : None.

Auteurs

Laure Gayraud (L)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France.

Marion Mortamais (M)

University of Montpellier, INSERM, Institute for Neurosciences of Montpellier INM, UMR1298, F-34091, Montpellier, France.

Cédric Schweitzer (C)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France; CHU de Bordeaux, Service d'Ophtalmologie, INSERM, U1219, Bordeaux, France.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.

Audrey Cougnard-Grégoire (A)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France.

Jean-François Korobelnik (JF)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France; CHU de Bordeaux, Service d'Ophtalmologie, INSERM, U1219, Bordeaux, France.

Marie-Noelle Delyfer (MN)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France; CHU de Bordeaux, Service d'Ophtalmologie, INSERM, U1219, Bordeaux, France.

Marie-Bénédicte Rougier (MB)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France; CHU de Bordeaux, Service d'Ophtalmologie, INSERM, U1219, Bordeaux, France.

Karen Leffondré (K)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France.

Catherine Helmer (C)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France.

Danielle Vienneau (D)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.

Claudine Berr (C)

University of Montpellier, INSERM, Institute for Neurosciences of Montpellier INM, UMR1298, F-34091, Montpellier, France.

Cécile Delcourt (C)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France. Electronic address: cecile.delcourt@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH